Radiation and androgen deprivation therapy with or without docetaxel in the management of non-metastatic unfavorable-risk prostate cancer: A prospective randomized trial.

Presenter

Anthony D'Amico

Anthony Victor D'Amico, MD, PhD

Dana-Farber Cancer Institute/Brigham and Women's Hospital

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT00116142

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5011)

DOI

10.1200/JCO.2021.39.15_suppl.5011

Abstract #

5011

Abstract Disclosures